Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy
and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to
Placebo in the Treatment of Adenoviral Conjunctivitis